Basukala O, Banks L
Viruses. 2021; 13(10).
PMID: 34696321
PMC: 8541208.
DOI: 10.3390/v13101892.
Medda A, Duca D, Chiocca S
Pathogens. 2021; 10(3).
PMID: 33668730
PMC: 7996217.
DOI: 10.3390/pathogens10030262.
Nor Rashid N, Yong Z, Yusof R, Watson R
Virol J. 2016; 13:2.
PMID: 26728921
PMC: 4700559.
DOI: 10.1186/s12985-015-0460-8.
Cesur O, Nicol C, Groves H, Mankouri J, Blair G, Stonehouse N
Viruses. 2015; 7(7):3443-61.
PMID: 26131956
PMC: 4517109.
DOI: 10.3390/v7072780.
Roman A, Munger K
Virology. 2013; 445(1-2):138-68.
PMID: 23731972
PMC: 3783579.
DOI: 10.1016/j.virol.2013.04.013.
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.
Klingelhutz A, Roman A
Virology. 2012; 424(2):77-98.
PMID: 22284986
PMC: 3703738.
DOI: 10.1016/j.virol.2011.12.018.
Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence.
Laurson J, Raj K
PLoS One. 2011; 6(6):e21501.
PMID: 21738683
PMC: 3126820.
DOI: 10.1371/journal.pone.0021501.
Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.
Genovese N, Broker T, Chow L
J Virol. 2011; 85(11):5546-54.
PMID: 21411531
PMC: 3094958.
DOI: 10.1128/JVI.02166-10.
Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.
Dreier K, Scheiden R, Lener B, Ehehalt D, Pircher H, Muller-Holzner E
Virology. 2010; 409(1):54-68.
PMID: 20970819
PMC: 3003157.
DOI: 10.1016/j.virol.2010.09.024.
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.
Barrow-Laing L, Chen W, Roman A
Virology. 2010; 400(2):233-9.
PMID: 20189212
PMC: 2861914.
DOI: 10.1016/j.virol.2010.01.034.
Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.
Amine A, Rivera S, Opolon P, Dekkal M, Biard D, Bouamar H
PLoS One. 2009; 4(3):e5018.
PMID: 19325708
PMC: 2657827.
DOI: 10.1371/journal.pone.0005018.
The human papillomavirus E7 oncoprotein.
McLaughlin-Drubin M, Munger K
Virology. 2008; 384(2):335-44.
PMID: 19007963
PMC: 2661820.
DOI: 10.1016/j.virol.2008.10.006.
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.
Genovese N, Sanjib Banerjee N, Broker T, Chow L
J Virol. 2008; 82(10):4862-73.
PMID: 18321970
PMC: 2346766.
DOI: 10.1128/JVI.01202-07.
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Sanjib Banerjee N, Genovese N, Noya F, Chien W, Broker T, Chow L
J Virol. 2006; 80(13):6517-24.
PMID: 16775338
PMC: 1488939.
DOI: 10.1128/JVI.02499-05.
Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang H, Yuan J, Cheung P, Chau D, Wong B, McManus B
Mol Cell Biol. 2005; 25(14):6247-58.
PMID: 15988033
PMC: 1168823.
DOI: 10.1128/MCB.25.14.6247-6258.2005.
Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation.
Southern S, Lewis M, Herrington C
Br J Cancer. 2004; 90(10):1949-54.
PMID: 15138476
PMC: 2409454.
DOI: 10.1038/sj.bjc.6601827.
Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells.
Tao M, Kruhlak M, Xia S, Androphy E, Zheng Z
J Virol. 2003; 77(24):13232-47.
PMID: 14645580
PMC: 296047.
DOI: 10.1128/jvi.77.24.13232-13247.2003.
Study of viral integration of HPV-16 in young patients with LSIL.
Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovagnoli M
J Clin Pathol. 2003; 56(7):532-6.
PMID: 12835300
PMC: 1770000.
DOI: 10.1136/jcp.56.7.532.
Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang S, McCance D
J Virol. 2002; 76(17):8710-21.
PMID: 12163591
PMC: 136974.
DOI: 10.1128/jvi.76.17.8710-8721.2002.
Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest.
Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao M, Tommasino M
J Virol. 2001; 75(10):4705-12.
PMID: 11312342
PMC: 114225.
DOI: 10.1128/JVI.75.10.4705-4712.2001.